PRAMIPEXOLE GxP pramipexole dihydrochloride 0.25 mg tablets blister pack

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Aktiivinen ainesosa:

pramipexole dihydrochloride monohydrate, Quantity: 0.25 mg

Saatavilla:

Arrotex Pharmaceuticals Pty Ltd

INN (Kansainvälinen yleisnimi):

pramipexole dihydrochloride monohydrate

Lääkemuoto:

Tablet, uncoated

Koostumus:

Excipient Ingredients: mannitol; pregelatinised maize starch; magnesium stearate; povidone; silicon dioxide

Antoreitti:

Oral

Kpl paketissa:

10, 30, 100

Prescription tyyppi:

(S4) Prescription Only Medicine

Käyttöaiheet:

Pramipexole tablets are indicated for:,-the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.

Tuoteyhteenveto:

Visual Identification: White, oval, uncoated tablets debossed with 'CL' and '3' on one side with breakline in between and a breakline on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Valtuutuksen tilan:

Licence status A

Valtuutus päivämäärä:

2014-09-23